Terran Develops TerXT Prodrug For Accelerated Schizophrenia Approval
20 May 2024 //
BUSINESSWIRE
Terran Biosciences Receives FDA Clearance for NM-101
20 Dec 2023 //
BUSINESSWIRE
Terran Biosciences Receives Notice of Allowance for Four US Patents
08 Dec 2023 //
BUSINESSWIRE
Terran announces exclusive licensing deal with Pierre Fabre for idazoxan
02 Jun 2023 //
PR NEWSWIRE
Terran discovers what may be first salts publishes PCT patent application
19 May 2023 //
PR NEWSWIRE
Terran announces publication of PCT patent application covering active forms of psilocin
24 Feb 2023 //
PR NEWSWIRE
Terran announces publication of PCT patent covering orally active forms of DMT
03 Feb 2023 //
PR NEWSWIRE
Concert Pharmaceuticals tunes up PhIII win for alopecia drug
24 May 2022 //
ENDPTS
Sanofi offloads 2 late-stage drugs to virtually unknown neuro & psychedelic
22 Apr 2022 //
ENDPTS